OL
ADPT icon

Odyssean LLC’s Adaptive Biotechnologies ADPT Stock Holding History

Odyssean LLC’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Buy
67,709
+51,592
+320% +$790K 0.24% 159
2026
Q1 		$224K Sell
16,117
-3,443
-18% -$54.9K 0.08% 353
2025
Q4 		$318K Buy
+19,560
New +$319K 0.23% 191

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Odyssean LLC's ADPT Position: Q2 2026 in Review

Odyssean LLC increased its Adaptive Biotechnologies (ADPT) stake by 320% in Q2 2026, buying an estimated $790K and bringing the position to 67,709 shares worth $1.45M. The position accounts for 0.24% of the portfolio, ranked #159.

Odyssean LLC first reported a position in ADPT in Q4 2025 and has held it in 3 quarters since. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Odyssean LLC held 67,709 shares of Adaptive Biotechnologies worth $1.45M as of Q2 2026.
  • Odyssean LLC bought 51,592 Adaptive Biotechnologies shares in Q2 2026, an estimated $790K.
  • Adaptive Biotechnologies made up 0.24% of Odyssean LLC's portfolio in Q2 2026, its #159 holding.
  • Odyssean LLC first reported a position in Adaptive Biotechnologies in Q4 2025 and has held it in 3 quarters since.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Odyssean LLC's 13F filing for Q2 2026, filed 14 Aug 2026.